From its offices in central Bangkok, Asia-Pacific IATEC CRO provides full services and management (support) for your phase I-IV clinical trials throughout the Asia-Pacific region, all conducted in an efficient and timely manner and in compliance with ICH Good Clinical Practice guidelines (ICH GCP), meeting the EMEA and the FDA regulatory standards.

In Asia-Pacific IATEC CRO, IATEC BV, a well-established CRO with a track record of more than 100 completed clinical studies from phase I to IV, 80 well-qualified employees, and representation in the Netherlands, Belgium, France, Israel and Thailand, collaborates with the Chulalongkorn University Intellectual Property Institute Foundation (CUIPIF) in Bangkok. Operations in Thailand are based on full adherence to IATEC’s Standard Operating Procedures (SOPs) throughout the organization, a process monitored by the Quality Assurance department in Amsterdam, the Netherlands.

A partnership with the Faculty of Medicine of Chulalongkorn University provides the company access to this institution’s outstanding clinical experts and opinion leaders, and to select patient populations throughout Thailand and other centers of excellence in the Asia-Pacific region.

At Asia-Pacific IATEC CRO we like to work closely with our clients, providing customized services and taking pride in our work. While the clients of the IATEC worldwide network range from smaller biotech firms to globally operating pharmaceutical companies, we find that in particular smaller to medium sized biotech and R&D companies enjoy working with us in a meeting of creative minds, and because of receiving flexible and more personalized services than larger CROs often can provide due to the size and nature of their organizations.

While Asia-Pacific IATEC CRO is a new company, we, the people who have founded and make up the company, combine many years of successful clinical trial conduct in Thailand and around the world.

The current Head Clinical and Office Operations, Mrs. Theshinee Chuenyam, RN, is US-NIH-certified to provide Expedited Adverse Event reporting training globally and she frequently provides ICH-GCP workshops throughout Thailand. In her former position with the HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) she gained extensive experience in being audited on multiple occasions by international pharmaceutical sponsors.

Our current CEO, Eugène Kroon, MD, is a US Board certified family physician with clinical experience in the US, Thailand and the Netherlands. He has extensive experience in all aspects of ICG-GCP guided clinical trial design, preparation and conduct in Thailand and the Netherlands and has worked closely with multiple pharmaceutical sponsors over the years. He has published in renowned peer reviewed medical journals, and has worked with the Clinton Foundation’s HIV/AIDS initiative.